SelK promotes glioblastoma cell proliferation by inhibiting β-TrCP1 mediated ubiquitin-dependent degradation of CDK4.

MLA

Li, Jizhen, et al. “SelK Promotes Glioblastoma Cell Proliferation by Inhibiting β-TrCP1 Mediated Ubiquitin-Dependent Degradation of CDK4.” Journal of Experimental & Clinical Cancer Research : CR, vol. 43, no. 1, Aug. 2024, p. 231. EBSCOhost, https://doi.org/10.1186/s13046-024-03157-x.

APA

Li, J., Zhao, L., Wu, Z., Huang, S., Wang, J., Chang, Y., Liu, L., Jin, H., Lu, J., Huang, C., Xie, Q., Huang, H., & Su, Z. (2024). SelK promotes glioblastoma cell proliferation by inhibiting β-TrCP1 mediated ubiquitin-dependent degradation of CDK4. Journal of Experimental & Clinical Cancer Research : CR, 43(1), 231. https://doi.org/10.1186/s13046-024-03157-x

Chicago

Li, Jizhen, Lingling Zhao, Zerui Wu, Shirui Huang, Junyu Wang, Yuanyuan Chang, Li Liu, et al. 2024. “SelK Promotes Glioblastoma Cell Proliferation by Inhibiting β-TrCP1 Mediated Ubiquitin-Dependent Degradation of CDK4.” Journal of Experimental & Clinical Cancer Research : CR 43 (1): 231. doi:10.1186/s13046-024-03157-x.